NodThera Limited

 

 

 

 

 

NodThera is a Cambridge (UK) based biotech engaged in inflammasome research. Our leading project is focused on developing inhibitors of the NLRP3 inflammasome for the treatment of inflammatory disorders with the first candidates scheduled for preclinical development in 2018.

 

For all enquiries please contact info@nodthera.com